Abbott Laboratories And More On CNBC's 'Final Trades'
Portfolio Pulse from Priya Nigam
On CNBC's 'Halftime Report Final Trades', several financial experts named their final trades. Bryn Talkington picked Innovator U.S. Equity Power Buffer ETF October (POCT), Stephen Weiss chose U.S. 10 Year Treasury Note, Brenda Vingiello selected Abbott Laboratories (ABT), and Shannon Saccocia picked Vanguard Real Estate Index Fund (VNQ). Abbott Laboratories recently agreed to acquire Bigfoot Biomedical and its shares gained 2.7% to close at $98.12 on Thursday.
September 29, 2023 | 12:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott Laboratories recently agreed to acquire Bigfoot Biomedical and its shares gained 2.7% to close at $98.12 on Thursday.
The acquisition of Bigfoot Biomedical by Abbott Laboratories could potentially strengthen its position in the market, which may have contributed to the rise in its share price. The recommendation by Brenda Vingiello also adds to the positive sentiment around the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Bryn Talkington of Requisite Capital Management named Innovator U.S. Equity Power Buffer ETF October (POCT) as her final trade.
The recommendation of POCT by Bryn Talkington could potentially influence investor sentiment towards the ETF. However, without additional information on the ETF's performance or market conditions, the impact on its price is uncertain.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 75
NEUTRAL IMPACT
Shannon Saccocia of Boston Private picked Vanguard Real Estate Index Fund (VNQ) as her final trade.
The recommendation of VNQ by Shannon Saccocia could potentially influence investor sentiment towards the ETF. However, without additional information on the ETF's performance or market conditions, the impact on its price is uncertain.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 75